BioMed Realty, one of the biggest labspace owners in the Boston area, recently acquired 215 First St., 150 Second St. and 11 ...

Community-Driven, Sustainable Development Project at 585 Kendall Reaches Major Construction Milestone ...

Other frequent patentees included Takeda, Cephalon ... Increased use of concurrent patent office proceedings Another interesting trend reflected in the report was the increase in the frequency ...

Mr. Liu joined Harrison Street in 2019 and heads the Asset Management of the Medical Office and Life Sciences ... with The Scripps Research Institute, Takeda Pharmaceuticals, The Burnham Institute ...

Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus ... commercial projects underway in Greater Boston right now. (Stubbornly high borrowing costs ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...

Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.

I am excited to guide Takeda through the next phase, together with our exceptional and talented people, while staying true to our strong culture that is rooted in our ...

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...